Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin D Levels Inversely Associated With Hypertension – Study

This article was originally published in The Tan Sheet

Executive Summary

Low levels of vitamin D were associated with high blood pressure among a large sample of the U.S. population, according to the results of a study in the July issue of the American Journal of Hypertension

You may also be interested in...



Calcium, vitamin D in older women

Postmenopausal women did not experience a drop in blood pressure or hypertension risk after seven years of calcium plus vitamin D3 supplementation, says a study published in the November issue of the American Heart Association's Hypertension journal. In the randomized, placebo-controlled trial, researchers led by Karen L. Margolis of Minneapolis-based HealthPartners Research Foundation assigned 36,282 subjects to take 1,000 mg of elemental calcium plus 400 IU of vitamin D3 daily or a placebo. The report says the trial was longer than other studies and lost few subjects during follow-up. The large subject pool allowed researchers to study subgroups hypothesized to benefit more from calcium and vitamin D, including blacks, Asians and hypertensive women. No subgroup displayed signs of benefiting from the supplement, the study says. A study of U.S. men and women published July 2007 found an inverse link between vitamin D levels and blood pressure (1"The Tan Sheet" Aug. 13, 2007, p. 10)

Calcium, vitamin D in older women

Postmenopausal women did not experience a drop in blood pressure or hypertension risk after seven years of calcium plus vitamin D3 supplementation, says a study published in the November issue of the American Heart Association's Hypertension journal. In the randomized, placebo-controlled trial, researchers led by Karen L. Margolis of Minneapolis-based HealthPartners Research Foundation assigned 36,282 subjects to take 1,000 mg of elemental calcium plus 400 IU of vitamin D3 daily or a placebo. The report says the trial was longer than other studies and lost few subjects during follow-up. The large subject pool allowed researchers to study subgroups hypothesized to benefit more from calcium and vitamin D, including blacks, Asians and hypertensive women. No subgroup displayed signs of benefiting from the supplement, the study says. A study of U.S. men and women published July 2007 found an inverse link between vitamin D levels and blood pressure (1"The Tan Sheet" Aug. 13, 2007, p. 10)

Calcium, vitamin D in older women

Postmenopausal women did not experience a drop in blood pressure or hypertension risk after seven years of calcium plus vitamin D3 supplementation, says a study published in the November issue of the American Heart Association's Hypertension journal. In the randomized, placebo-controlled trial, researchers led by Karen L. Margolis of Minneapolis-based HealthPartners Research Foundation assigned 36,282 subjects to take 1,000 mg of elemental calcium plus 400 IU of vitamin D3 daily or a placebo. The report says the trial was longer than other studies and lost few subjects during follow-up. The large subject pool allowed researchers to study subgroups hypothesized to benefit more from calcium and vitamin D, including blacks, Asians and hypertensive women. No subgroup displayed signs of benefiting from the supplement, the study says. A study of U.S. men and women published July 2007 found an inverse link between vitamin D levels and blood pressure (1"The Tan Sheet" Aug. 13, 2007, p. 10)

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100807

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel